These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3458531

  • 21. Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy.
    Torti FM, Bristow MR, Howes AE, Aston D, Stockdale FE, Carter SK, Kohler M, Brown BW, Billingham ME.
    Ann Intern Med; 1983 Dec; 99(6):745-9. PubMed ID: 6651020
    [Abstract] [Full Text] [Related]

  • 22. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN.
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [Abstract] [Full Text] [Related]

  • 23. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.
    Mason JW, Bristow MR, Billingham ME, Daniels JR.
    Cancer Treat Rep; 1978 Jun; 62(6):857-64. PubMed ID: 667859
    [Abstract] [Full Text] [Related]

  • 24. [Serial determination of anthracycline poisoning in children].
    Stein JI, Langevin A, Benson LN, Souza MD, Wilson G, Chan H.
    Wien Klin Wochenschr; 1989 Jan 06; 101(1):45-8. PubMed ID: 2913725
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard T, Andersen PK.
    J Natl Cancer Inst; 2008 Aug 06; 100(15):1058-67. PubMed ID: 18664656
    [Abstract] [Full Text] [Related]

  • 27. Expectations and limitations of endomyocardial biopsy.
    Mills AS, Hastillo A, Thompson JA, Hess ML.
    Can J Cardiol; 1985 Aug 06; 1(6):358-62. PubMed ID: 3915878
    [Abstract] [Full Text] [Related]

  • 28. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O, Le QH, Moullet I, Pauli E, Salles G, Espinouse D, Dumontet C, Thieblemont C, Arnaud P, Antal D, Bouafia F, Coiffier B.
    J Clin Oncol; 2004 May 15; 22(10):1864-71. PubMed ID: 15143078
    [Abstract] [Full Text] [Related]

  • 29. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
    Friedman MA, Bozdech MJ, Billingham ME, Rider AK.
    JAMA; 1978 Oct 06; 240(15):1603-6. PubMed ID: 691145
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR, Della Torre P, Mazué G, Sullivan TM, Robbins TL, Hagerman LM, Podestà A, Pinciroli G.
    Cancer Res; 1996 Sep 15; 56(18):4200-4. PubMed ID: 8797592
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
    Crescimanno M, Flandina C, Rausa L, Sanguedolce R, D'Alessandro N.
    Chemioterapia; 1988 Feb 15; 7(1):53-9. PubMed ID: 3163942
    [Abstract] [Full Text] [Related]

  • 35. Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia.
    Bhutani M, Kumar L, Vora A, Bhardwaj N, Pathak AK, Singh R, Kochupillai V.
    Am J Hematol; 2002 Dec 15; 71(4):241-7. PubMed ID: 12447951
    [Abstract] [Full Text] [Related]

  • 36. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S, Tucci A, Villani G, Carteni G, Spadini N, Palumbo R.
    Anticancer Res; 2000 Dec 15; 20(1B):485-91. PubMed ID: 10769710
    [Abstract] [Full Text] [Related]

  • 37. Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats.
    Karagoz B, Suleymanoglu S, Uzun G, Bilgi O, Aydinoz S, Haholu A, Turken O, Onem Y, Kandemir EG.
    Basic Clin Pharmacol Toxicol; 2008 Mar 15; 102(3):287-92. PubMed ID: 18248515
    [Abstract] [Full Text] [Related]

  • 38. Cardiac evaluation of mitoxantrone.
    Unverferth DV, Unverferth BJ, Balcerzak SP, Bashore TA, Neidhart JA.
    Cancer Treat Rep; 1983 Apr 15; 67(4):343-50. PubMed ID: 6850653
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.